Help Us Preserve and Share UC's History
Time capsule to be sealed during Homecoming weekend
In celebrating the ongoing journey of the university and the UC family, our Bicentennial has been highlighting the connections between our past, present and future. In that spirit, the UC Alumni Association is partnering with the UC Bicentennial to create a special time capsule that will “travel” through the next 50 years. It will be filled with a variety of artifacts, sealed within Fifth Third Arena at the UC Bicentennial Bash during Homecoming Weekend, then reopened by members of the Bearcat family in 2069 when UC marks its 250th anniversary.
We would love to receive your thoughts and submissions for this fun project. All the details are here, including some idea-starters for the kinds of things new generations might find compelling a half century from now. But we really want to tap into the imaginations of today’s Bearcats in order to creatively reach out to the Bearcats of tomorrow. What would you like to see go into the time capsule?
Related Stories
A jolly good trip: Bearcats take on London for fragrance company
May 15, 2026
Six NEXT Innovation Scholars at the University of Cincinnati traveled to London to transform field research into actionable recommendations for British luxury bath, body and fragrance brand Molton Brown.
UC Blue Ash celebrates top students and recognizes Honor Student of the Year
May 14, 2026
The University of Cincinnati Blue Ash College recently hosted a special event that celebrated students for exceptional achievements during the 2025-26 academic year. The honorees included academic award winners, student engagement award winners, Latin Honors graduates, and the 2026 UC Blue Ash College Honor Student of the Year.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.